- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index
Treatment of infection in burns
especially susceptible to this complication with catheter infection rates reported ranging from 8–57% [10, 11]. Central line sepsis is associated with prolonged indwelling central venous catheters. Meticulous sterile technique is essential during line placement to avoid introduction of potential pathogens. The use of antimicrobial coated catheters and rotation of the catheter site, tubing and apparatus every 72 hours have been reported to have a decrease in catheter infection rates, however these studies are flawed and more valid conclusions would be obtained with a prospective randomized study [12, 13]. All areas should be carefully prepped and draped with Betadine or Chlorhexidine solution and the physician gowned and gloved appropriately prior to insertion [14]. Central line sepsis may be primary in which the central line is the original focus of infection. It also may be secondary, in which case, the catheter tip is seeded and serves as a nidus for continued shedding of microorganisms into the blood stream. Signs of erythema or inflammation around the insertion site should alert the clinician to the potential for a line infection. However, it is important to realize that there may be a significant infection of the catheter tip even when skin surrounding the insertion site appears normal. Central lines can be associated with the development of both gram negative and gram-positive sepsis. The key concept to recognize is that central lines represent a foreign body and as such are prone to microbial seeding. There is significant controversy with regard to the frequency of line changes necessary to avoid catheter-related infection. Frequent line changes may actually increase the risk of central line sepsis. Once a catheter-related infection is suspected, the central venous line should be promptly removed and the tip cultured. Systemic antimicrobial therapy can be initiated for a short time, but generally once the source of infection has been removed the patient should improve quickly. Careful records of previously cannulated sites can allow for sequential venotomy, examination for ultra luminal pus and histologic examination for intimal colonization. Upon confirmation of the diagnosis, immediate operative excision is essential to prevent progressive sepsis. Entire excision of a vein to the port of entry into the central circulation may be required because of the tendency of phlebitis to migrate to vein valves, leaving an ap-
parently normal vein in between the infected foci. The subcutaneous tissue and skin should be packed open where a grossly purulent vein is removed and allowed to granulate and close by secondary intention.
Urinary tract infection
Urinary tract infections are usually associated with prolonged and often unnecessary catheterization, as it is rarely indicated to leave a catheter in place for more than a few days. Routine monitoring of urine from indwelling catheters should be done by needle aspirates on a regular basis two to three times a week. Urinary tract infections can generally be divided into upper and lower urinary tract infections. True pyelonephritis is very rare in thermally injured patients; however, lower urinary tract infection can occur as a result of a chronic indwelling Foley catheter. The diagnosis should be suspected when there are greater than 1 × 105 organisms cultured from urine specimen. Also urinalysis may reveal white cells and cellular debris associated with active infection. The most common organisms are gram-negative pathogens such as Escherichia coli. The appropriate treatment consists of either exchange or removal of the foley catheter and 7–10 day course of an antimicrobial with good gram-negative coverage. Fluroquinolones such as ciprofloxacin are often very effective for uncomplicated cases. Candiduria is often insignificant but may reflect active infection or septicemia, especially when mycelia can be demonstrated. When present, an active infection with Candida species usually responds well to low doses of fluconazole. If there is suspicion of an ascending infection, more aggressive treatment with prolonged systemic antimicrobials is warranted.
Tracheobronchitis
Smoke inhalation injury is a chemical trancheobronchitis that results from the inhalation of the incomplete products of combustion and is often found in association with severe burn injury. Inhalation injury impairs the mucociliary transport mechanism and predisposes patients to colonization of the tracheobronchial tree by microorganisms. Additionally, direct cellular injury to the respiratory epitheli-
225
G. G. Gauglitz et al.
um results in the formation of extensive fibrinous casts composed of inflammatory exudates and sloughed cells. Increased bronchial blood flow leads to increased airway edema. As necrotic debris accumulates and airway edema is increased, patients become susceptible to post-obstructive atelectasis and pneumonia. There is no specific treatment for tracheobronchitis other than aggressive pulmonary toilet and supportive measures. It is important to realize, however, that an upper respiratory infection can quickly turn into a lower respiratory infection with significant mortality. Pneumonia has been shown to independently increase burn mortality by 40%, and the combination of inhalation injury and pneumonia leads to a 60% increase in deaths. Inhalation injury was also found to be associated with a twofold higher risk of developing nosocomial pneumonia than with burns alone. Children and the elderly are especially prone to pneumonia due to a limited physiologic reserve.
Pneumonia
The diagnosis of pneumonia in severely burned patients is exceedingly problematic. During the acute phase of injury these patients demonstrate a hypermetabolic response characterized by increased basal metabolic rate and resetting of their hypothalamic temperature set point. The increased levels of catecholamines result in a hyperdynamic circulation. For these reasons, many of the usual signs and symptoms of pneumonia are unreliable in the severely burn patients. Fever, leucocytosis, tachycardia and tachypnea may all be present even in the absence of an infection. Sputum examination is rarely helpful since specimens are often contaminated with oropharyngeal flora. If sputum expectoration is chosen, examination should include a variety of criteria such as color, amount, consistency and odor of the specimen. Muco-purulent sputum is most commonly found with bacterial pneumonia or bronchitis. Scant or watery sputum is often related to viral and other atypical pneumonias. “Rusty” sputum indicates alveolar involvement and has been most commonly associated with pneumococcal pneumonia. Dark red, mucoid sputum suggests Friedlander’s pneumonia caused by encapsulated K. I. Pneumonia. Foul-smelling sputum is associated with mixed anaerobic infections most commonly seen with as-
piration [14]. More invasive sampling techniques such as brochoalveolar lavage have been advocated; however, these have also been shown to be less than ideal for establishing a diagnosis of pneumonia. Radiographic findings can be helpful if they reveal lobar consolidation. Unfortunately, concomitant inhalation injury and changes in pulmonary vascular permeability more often result in diffuse nonspecific radiographic changes consistent with noncardiogenic pulmonary edema. Pneumonias can result from descending infection and have clearly been shown to increase the incidence and the mortality of nosocomial pneumonia in the burn population. Generally, patients with a significant inhalation injury and pneumonia develop atelectasis, ventilationperfusion mismatch, arterial hypoxia and respiratory failure. Prolonged mechanical ventilation leads to inevitable barotraumas and further worsening of pulmonary status in these patients. Ventilator-asso- ciated pneumonia (VAP) specifically refers to pneumonia that develops more than 48 hours after intubation (late-onset VAP) in mechanically ventilated patients who had no clinical evidence suggesting the presence or likely development of pneumonia at the time of intubation. VAP that occurs within 48 hours of intubation is frequently the result of aspiration and usually yields a better prognosis than late-onset VAP, which is more often caused by antibioticresistant bacteria. While broncho-alveolar lavage has been to correlate better with the presence of trancheobronchitis than with radiographic evidence of true pneumonia, it is the best available tool. For this reason, a positive lavage in the appropriate clinical context mandates aggressive intervention. These nosocomial pneumonias are generally gram-negative infections and systemic antimicrobial therapy with multiple agents is generally required until the infection resolves clinically. Amikacain and piperacillin with tazobactam or ceftazidime are generally recommended for serious infections, but antibiotics should be selected on the basis of susceptibility patterns in each hospital. Once cultures are returned, antimicrobial coverage may be narrowed appropriately.
Sepsis in the burn patient
Sepsis is one of the leading causes of morbidity and mortality in critically ill patients [15]. Severely burned
226
Treatment of infection in burns
patients are markedly susceptible to a variety of infectious complications [16]. Sepsis may result from seeding of the bloodstream from the burn wound, the respiratory tract, the gastrointestinal tract, and the urinary tract and central venous catheters. The burn wound and the lungs account for the vast majority of cases. The immunocompromised state of the burned patient is associated with multiple defects of the humoral and cellular components of both the nonspecific host defense system and the specific immune defense system and is markedly contributing to the increased susceptibility to infection. It is important to differentiate bacteremia from septicemia. Bacteremia refers to the presence of bacteria in the blood stream and may occur transiently after burn wound manipulation or excision. This transient bacteremia generally resolves and is not associated with any significant morbidity. Septicemia, however, implies a widespread response at the tissue level to bacteria or their products and toxins. Traditionally sepsis is categorized as gram-posi- tive or gram-negative. Gram-negative sepsis is by far the most predominant in severely burned patients.
There are excellent criteria for the diagnosis of infection and sepsis in most patients, but the standard diagnoses for infection and sepsis really do not apply to burn patients 17. Burn patients lose their primary barrier to microorganism invasion so they are constantly and chronically exposed to the environment. In response to this exposure, inflammatory mediators that change the baseline metabolic profile of the burn patient are continuously released. The baseline temperature is reset to about 38.5°C, and tachycardia and tachypnea persist for months in patients with extensive burns. Continuous exposure leads to significant changes in the white blood cell (WBC) count, making leukocytosis a poor indicator of sepsis.
The burn sepsis definition must therefore distinguish changes in patient status as the result of infection due to a microbial entity from the alterations secondary to the burn injury itself or associated events (such as inhalation injury). Several of these global changes are based on the fact that patients with extensive burns develop a hypermetabolic state that surpasses that of any other patient group.
Current definitions for sepsis and infection have many criteria (fever, tachycardia, tachypnea, leuko-
cytosis) that are routinely found in patients with extensive burns, making these current definitions less applicable to the burn population. The diagnosis of sepsis is aclinical diagnosis. Laboratory studies are supportive. A patient who is adequately resuscitated and becomes hemodynamically unstable should alert the clinician to the possibility of either active bleeding or the development of septic shock. The five cardinal signs of sepsis are hyperventilation, thrombocytopenia, hyperglycemia, obtundation and hypothermia. Leucocytosis and fever are also important, but must be interpreted with caution in this setting. Based on the American Burn Association Consensus Conference to Define Sepsis and Infection in Burns, sepsis is defined by the criteria depicted in Tables 1 and 2 [17, 18].
A septic source can be documented as:
1) Burn wound biopsy with > 105 organisms/gm tissue and/or histologic evidence of viable tissue invasion
2) Positive blood culture
3) Urinary tract infection with > 105 organisms/ ml urine of
4) Pulmonary infection
Local evidence of invasive wound infection includes black or brown patches of wound discoloration, rapid eschar separation, conversion of wounds to full thickness, spreading peri-wound erythema, punctate hemorrhagic subeschar lesions, and violaceous
Table 1. Definition of sepsis
Burn |
Modified ACCP/SCCM |
At least 3 of the following: At least 2 of the following: |
|
r T > 38.5 or < 36.5 °C |
r T > 38.5 or < 36.5°C |
r Progressive tachycardia |
r HR>20% above NL |
r Progressive tachypnea |
for age |
r WBC > 12,000 or |
r RR > 20% above NL |
< 4,000 |
for age or |
r Refractory hypotension |
PaCO2 < 32 torr |
r Thrombocytopenia |
r WBC > 12,000 |
r Hyperglycemia |
or < 4,000 |
r Enteral Feeding |
AND |
Intolerance |
r Bacteremia or fungemia |
AND |
r Pathologic tissue source |
r Pathologic tissue source |
identified |
identified |
|
Hart et al. (2000) Determinants of skeletal muscle catabolism after severe burn. Ann Surg 233(4): 455–465
227